Login/Register
  • 中文
  • English

News

Foresee Pharmaceuticals submits application to TFDA for Phase III clinical trial of drug for central precocious puberty in children

The company has applied for a Phase III clinical trial of FP-001 42 mg (six-month extended-release injection) in children with central precocious puberty.

Read more
Dec 16, 2022
Polaris' new drug for NASH applies for phase II clinical trial in Taiwan
Cnyes.com
Dec 16, 2022
Interdisciplinary collaboration: Oral cancer patients benefited with the Tissue Resection Power-assist System
China Times
Dec 15, 2022
Leadtek's medical business to increase 20% of revenue in Japan next year
Cnyes.com
Dec 15, 2022
PharmaEssentia: Data show importance of proactive care earlier in the Polycythemia Vera patient journey
PharmaEssentia
Dec 15, 2022
Quanta develops its digital transformation partnership and expands 5G and AI in non-IT sectors
Investor.com.tw
Dec 14, 2022
V5 Technologies nets TFDA approval of Lung Image Aided Interpretation Software
Economic Daily
Dec 13, 2022
Pharmaceuticals and APIs benefit from drug shortages in China and Europe
Investor.com.tw
Dec 12, 2022
12 Taiwanese biotech companies reap profits of November
Commercial Times
Dec 12, 2022
Acepodia may be listing in Taiwan instead of Nasdaq
Economic Daily

Most Watched

Recommended

Axonal Brain Age examination service
AcroViz
A Method Of Non-contrast Magnetic Resonance Technology To Obtain Pelvic Veins Model And Analyze Hemodynamics
Chang Gung Medical Foundation
UniTranz-RT® Transport System
ICON INC.

Industry Watch

Read more